Claritev Corporation
NYSE:CTEVMedical - Healthcare Information Services
+$0.42 today
- Market cap
- $380.77M
- Beta
- 0.77
- P/E (TTM)
- -1.8
- EPS (TTM)
- -$17.16
Volume 0.31M
Average 0.14M
CTEV Operating Income
Profit from core operations after operating expenses, before interest and taxes.
Claritev CorporationNYSE: CTEV
Operating Income · Q1 FY2026 · quarter ended Mar 2026
Operating income dips below year-ago levels
Q1 FY2026 operating income of $6.68M fell 31.5% year over year, behind the +104.7% change in trailing-twelve-month operating income. Sequentially, it fell 23.0% from the prior quarter.
Context
- Operating income amounted to 4.7% of revenue in FY2025, down 144.7 pp from a year earlier.
- Operating income increased in 2 of the last 3 fiscal years.
What to watch
Whether operating income reaches the consensus estimate from 2 analysts of $111.66M (+147.8%) for the fiscal year ending Dec 2026, a step up from the +103.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $6.68M-23.0% QoQ
- Last fiscal yearDec 2025
- $45.06M+103.2% YoY
- LTMMar 2026
- $41.99M+104.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -31.5% | +82.7% | +114.2 pp |
| 1 year | +103.2% | +147.8% | +44.6 pp |
| 3-year CAGR | — | +51.4% | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Income history
USD · from the income statement
- Latest · FY2025
- 45.06M USD
- Year-over-year change
- +103.2%
- 4-year CAGR
- -41.6%
| Period | Period end | Operating Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 45.06M | +103.2% |
| FY2024 | 2024-12-31 | (1.39B) | -958.1% |
| FY2023 | 2023-12-31 | 161.98M | +144.7% |
| FY2022 | 2022-12-31 | (362.73M) | -193.9% |
| FY2021 | 2021-12-31 | 386.12M | — |
Operating Income vs competitors
How CTEV compares with its peers on the latest reported figures
- CTEV's LTM Mar 2026 operating income of $41.99M is the 4th highest of the 11 companies compared; the peer median is -$13.35M.
- Its year-over-year change of +104.7% is the 2nd highest of 11, against a peer median of -19.6%.
- Operating income amounts to 4.3% of revenue for CTEV, versus a peer median of 10.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $123.9M | +1284.2% | -34.1% | 7.5% | |
| LTM Mar 2026 | $84.56M | +3.3% | +269.2% | 10.7% | |
| LTM Mar 2026 | $79.83M | -27.5% | -24.4% | 21.3% | |
CTEVClaritev Corporation | LTM Mar 2026 | $41.99M | +104.7% | — | 4.3% |
| LTM Mar 2026 | $27.95M | +23.4% | +18.7% | 32.4% | |
| LTM Mar 2026 | -$12.9M | -91.4% | — | 5.9% | |
| LTM Sep 2026 | -$13.81M | -450.4% | — | 5.2% | |
| LTM Mar 2026 | -$16.29M | +43.2% | — | 0.9% | |
| LTM Mar 2026 | -$202.84M | -37.3% | — | 34.9% | |
| LTM Jun 2026 | -$217.84M | -67.7% | — | 11441.4% | |
| LTM Mar 2026 | -$237.56M | -11.7% | — | — | |
| Peer median (excluding CTEV) | -$13.35M | -19.6% | -2.9% | 10.7% | |
Competitors are the stored peer set for CTEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.12B | 1.08B | 961.52M | 930.62M | 965.41M |
| Cost of Revenue | 175.29M | 204.1M | 235.47M | 239.4M | 698.84M |
| Gross Profit | 942.31M | 875.62M | 726.06M | 691.22M | 266.58M |
| Gross Margin | 84.3% | 81.1% | 75.5% | 74.3% | 27.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 151.1M | 132.14M | 135.99M | 160.22M | 221.52M |
| Operating Expenses | 556.19M | 1.24B | 564.07M | 2.08B | 221.52M |
| Depreciation & Amortization | 412.06M | 415.66M | 425.79M | 436.44M | 448.45M |
| EBITDA | 814.99M | 158.32M | 651.93M | (1.01B) | 475.44M |
| EBITDA Margin | 72.9% | 14.7% | 67.8% | -108.3% | 49.2% |
| Operating Income | 386.12M | (362.73M) | 161.98M | (1.39B) | 45.06M |
| Operating Margin | 34.5% | -33.6% | 16.8% | -149.4% | 4.7% |
| Interest Income | 30K | 3.5M | 8.23M | 3.13M | 1.56M |
| Interest Expense | 267.48M | 303.4M | 333.21M | 326.37M | 400.07M |
| Other Income / Expenses | (250.67M) | (198.01M) | (269.04M) | (380.78M) | (418.14M) |
| Income Before Tax | 135.45M | (560.74M) | (107.06M) | (1.77B) | (373.08M) |
| Pre-Tax Margin | 12.1% | -51.9% | -11.1% | -190.3% | -38.6% |
| Income Tax Expense | 33.37M | 12.17M | (15.36M) | (124.88M) | (88.8M) |
| Net Income | 102.08M | (572.91M) | (91.7M) | (1.65B) | (284.28M) |
| Net Margin | 9.1% | -53.1% | -9.5% | -176.9% | -29.4% |
| EPS (Basic) | 6.40 | (35.87) | (5.69) | (101.92) | (17.30) |
| EPS (Diluted) | 6.40 | (35.87) | (5.69) | (101.92) | (17.30) |
| Weighted Avg Shares | 16.28M | 15.97M | 16.13M | 16.15M | 16.43M |
| Weighted Avg Shares (Diluted) | 16.29M | 15.97M | 16.13M | 16.15M | 16.43M |
Claritev Corporation
NYSE:CTEV
Intrinsic Alpha fair value
Locked
Current Price
$22.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.